Related Experiment Video
Updated: Aug 8, 2026

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Case report - atypical hemolytic uremic syndrome triggered by influenza B
Robin Kobbe1, Raphael Schild2, Martin Christner2
1University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246, Hamburg, Germany. r.kobbe@uke.de.
Background:
Influenza A infections have been described to cause secondary hemolytic uremic syndrome and to trigger atypical hemolytic uremic syndrome (aHUS) in individuals with an underlying genetic complement dysregulation. To date, influenza B has not been reported to trigger aHUS.
Case Presentation:
A 6-month-old boy presented with hemolytic uremic syndrome triggered by influenza B infection. Initially the child recovered spontaneously. When he relapsed Eculizumab treatment was initiated, resulting in complete and sustained remission. A pathogenic mutation in membrane cofactor protein (MCP) was detected.
Conclusion:
Influenza B is a trigger for aHUS and might be underreported as such. Influenza vaccination may protect patients at risk.
More Related Videos
04:47A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
Related Concept Videos
Viral Recombination
Poliomyelitis
Influenza
Respiratory Syncytial Virus Disease
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology